These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17131516)

  • 1. Appetite suppressants and pulmonary hypertension: a long-term risk.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
    Olschewski H
    Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
    [No Abstract]   [Full Text] [Related]  

  • 4. Too late, again?
    Jones NL
    Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Appetite depressants and pulmonary hypertension].
    Hellermann J; Salomon F
    Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of heart-valve abnormalities with appetite suppressants.
    Baird IM
    Lancet; 1998 Oct; 352(9138):1403-4. PubMed ID: 9807983
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 9. Debate over dexfenfluramine.
    Deitel M
    CMAJ; 1997 Jul; 157(1):14, 16. PubMed ID: 9220935
    [No Abstract]   [Full Text] [Related]  

  • 10. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to discover unexpected adverse effects? Heart valve lesions caused by appetite suppressants reported in the USA, but not in Europe].
    Rössner S
    Lakartidningen; 1999 Dec; 96(50):5654-5. PubMed ID: 10643234
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?
    Voelkel NF; Clarke WR; Higenbottam T
    Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009
    [No Abstract]   [Full Text] [Related]  

  • 13. Appetite-suppressant drugs and the risk of primary pulmonary hypertension?
    Deitel M
    Obes Surg; 1997 Feb; 7(1):3-4. PubMed ID: 9730529
    [No Abstract]   [Full Text] [Related]  

  • 14. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
    Humbert M; Deng Z; Simonneau G; Barst RJ; Sitbon O; Wolf M; Cuervo N; Moore KJ; Hodge SE; Knowles JA; Morse JH
    Eur Respir J; 2002 Sep; 20(3):518-23. PubMed ID: 12358323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary hypertension following use of appetite depressants?].
    Homann G
    Med Klin; 1974 Feb; 69(5):211. PubMed ID: 4819931
    [No Abstract]   [Full Text] [Related]  

  • 18. Appetite-suppressant drugs and valvular heart disease.
    Williamson DF; Yanovski SZ
    N Engl J Med; 1999 Feb; 340(6):476; author reply 478-80. PubMed ID: 9988618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials do not guarantee the safety of the medicines. The case of fenfluramine and dexfenfluramine].
    García del Pozo J; García-Pando AC; Rueda AM; Martín Arias LH
    Med Clin (Barc); 1999 Nov; 113(15):598. PubMed ID: 10605688
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.
    Mark EJ; Patalas ED; Chang HT; Evans RJ; Kessler SC
    N Engl J Med; 1997 Aug; 337(9):602-6. PubMed ID: 9271482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.